Rock Hill’s Piedmont Medical Center has earned a three-year accreditation for its cancer program.
The Commission on Cancer gave Piedmont the accreditation following an on-site evaluation by a physician surveyor during which the facility demonstrates a Commendation level of compliance with one or more standards that represent the full scope of the cancer program: cancer committee leadership, cancer data management, clinical services, research, community outreach and quality improvement.
Established in 1922 by the American College of Surgeons , the Commission on Cancer is a consortium of professional organizations dedicated to improving survival rates and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons and 49 national organizations that reflect the full spectrum of cancer care.
The core functions of the Commission on Cancer include setting standards of quality, multidisciplinary cancer patient care; surveying facilities to evaluate compliance with the 26 Commission on Cancer standards; collecting standardized and quality data from accredited facilities; and using the data to develop effective educational interventions to improve cancer care outcomes at the national, state and local level.
The American Cancer Society (ACS) estimates that more that 1.6 million cases of cancer will be diagnosed in 2012. There are currently more than 1,500 Commission on Cancer-accredited cancer programs in the US and Puerto Rico, representing close to 30 percent of all hospitals. This 30 percent of hospitals diagnose and/or treat approximately 80 percent of all newly diagnosed cancer patients each year. In addition, a national network of more than 1,650 volunteer Cancer Liaison Physicians provides leadership and support for the Commission on Cancer Accreditation Program and other Commission on Cancer activities at these local facilities.
The Accreditation Program, a component of the Commission on Cancer, sets quality-of-care standards for cancer programs and reviews the programs to ensure they conform to those standards. Accreditation by the Commission on Cancer is given only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and that undergo a rigorous evaluation process and review of their performance. To maintain accreditation, facilities with Commission on Cancer-accredited cancer programs must undergo an on-site review every three years.
Receiving care at a Commission on Cancer-accredited cancer program ensures that a patient will have access to:
Cancer patient data are reported by each Commission on Cancer-accredited cancer program to the Commission on Cancer’s National Cancer Data Base (NCDB), a joint CoC/American Cancer Society program. The NCDB currently contains patient demographics, tumor characteristics, and treatment and outcomes information for almost 28 million cancer patients diagnosed and treated at hospital cancer programs in the US between 1985 and 2004. These data account for approximately two-thirds of newly diagnosed cancer cases in the US each year.
NCDB data is regularly used to monitor and improve quality of patient care delivered in Commission on Cancer-accredited cancer programs. The Commission on Cancer requires programs to implement quality improvement initiatives that promote the delivery of quality, multidisciplinary cancer care and lead to ongoing educational interventions with local providers in the Commission on Cancer-accredited cancer programs.
Through an exclusive partnership with the American Cancer Society, the Commission on Cancer provides the public with information on the resources, services and cancer treatment experience for each Commission on Cancer-accredited cancer program. This information is shared with the public on the American Cancer Society’s website at www.cancer.org and through the American Cancer Society’s National Cancer Information Center at 1-800-ACS-2345.